DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event

Author's Avatar
Dec 13, 2021

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today that the Company is participating in the LifeSci Partners 11th Annual Corporate Access Event, to be held virtually from January 5-7, 2022.